Body Handbook კატალოგი პროფილი რეიტინგი
გარეგნობა BODY HANDBOOK
გარეგნობა · §689
finasteride-ი თმის ცვენის წინააღმდეგ
Male-pattern baldness runs on one hormone, and a daily pill turns it down. Two do it: finasteride and dutasteride, the only proven way to stop the slow loss. About half of men who take one see real regrowth by one to two years, a third hold what they have, and one in six keeps losing anyway Kaufman et al. 1998. The catch is honest: roughly two percent get sexual side effects. Starting early matters more than which pill you pick.
გადაწყვიტე · ყოველდღე მტკიცებულება ძლიერი თავი გარეგნობა

The hormone is DHT. Genetically prone follicles on top of the scalp shrink each cycle under dihydrotestosterone, the hair going fine, then wispy, then invisible. Finasteride blocks the enzyme that makes DHT and drops scalp levels by about two-thirds 1; dutasteride blocks both forms and cuts blood DHT by around ninety percent 2. Follicles fully scarred over are past saving, so the clock matters.

It works, and the answer has held for thirty years. At two years, 48% of treated men had measurably more crown hair and 83% held steady or improved, against 7% and 28% on placebo 3; at five years the effect held 4. Dutasteride does the same harder at similar side-effect rates 5, but it's on-label for hair loss only in South Korea and Japan, so a willing prescriber is harder to find 6.

One pill a day, and don't quit at the shed. The first month or two brings a wave of shedding that looks like the drug making things worse. It's the opposite: dormant follicles waking up in sync and pushing old hairs out first. The rebuild peaks at one to two years 3. It suppresses rather than cures: stop and the decline resumes within a year 4.

The years, for the half who respond. Months one to three look alarming. By six to twelve the part holds and your barber asks if you grew it out. By year two nobody mentions it 4. The pill won't give back the hair you had at twenty; it changes which photo you take at forty.

Minoxidil is the standard add-on. Topical 5% works on blood flow rather than DHT, and a pill plus minoxidil beats either alone 7. A topical finasteride spray gets similar hair counts with far less blood DHT 8. A transplant puts hair where there's none but doesn't stop native thinning, so surgeons keep patients on the pill. Saw palmetto, the "natural" version, hits the same enzyme too weakly to count on.

The fine print — when to skip it, and what people get wrong

Sexual side effects run about two percent above placebo, usually reversing on stopping; a minority persist 3 9. A pregnant woman must not handle broken tablets 10. Before a PSA test, tell the lab it halves the reading 11.

Causes prostate cancer: eighteen-year follow-up showed no survival difference 12. Dutasteride is more dangerous: head-to-head side-effect rates are similar 5. Restores a twenty-year-old hairline: mostly no; the vertex responds, temples least 13.

References
  1. 1Mella JM, Perret MC, Manzotti M, Catalano HN, Guyatt G (2010). Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review. Archives of Dermatology. link
  2. 2Gubelin Harcha W, Barboza Martínez J, Tsai TF, et al. (2014). A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. Journal of the American Academy of Dermatology. link
  3. 3Kaufman KD, Olsen EA, Whiting D, et al. (1998). Finasteride in the treatment of men with androgenetic alopecia. Journal of the American Academy of Dermatology. link
  4. 4Whiting D, Olsen EA, Savin R, et al. (2003). Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss. European Journal of Dermatology. link
  5. 5Zhou Z, Song S, Gao Z, et al. (2019). The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis. Clinical Interventions in Aging. link
  6. 6Eun HC, Kwon OS, Yeon JH, et al. (2010). Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study. Journal of the American Academy of Dermatology. link
  7. 7Gupta AK, Bamimore MA, Foley KA (2022). Efficacy of non-surgical treatments for androgenetic alopecia in men and women: a systematic review with network meta-analyses, and an assessment of evidence quality. Journal of Dermatological Treatment. link
  8. 8Piraccini BM, Blume-Peytavi U, Scarci F, et al. (2022). Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial. Journal of the European Academy of Dermatology and Venereology. link
  9. 9Irwig MS, Kolukula S (2011). Persistent sexual side effects of finasteride for male pattern hair loss. Journal of Sexual Medicine. link
  10. 10FDA (1997). Propecia (finasteride) 1 mg approval — prescribing information. link
  11. 11D'Amico AV, Roehrborn CG (2007). Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial. The Lancet Oncology. link
  12. 12Thompson IM Jr, Goodman PJ, Tangen CM, et al. (2013). Long-term survival of participants in the prostate cancer prevention trial. New England Journal of Medicine. link
  13. 13Leyden J, Dunlap F, Miller B, et al. (1999). Finasteride in the treatment of men with frontal male pattern hair loss. Journal of the American Academy of Dermatology. link
·
689